Mather Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$937K Sell
10,990
-36
-0.3% -$3.21K 0.01% 345
2025
Q4
$871K Buy
11,026
+3,409
+45% +$267K 0.01% 306
2025
Q3
$609K Buy
7,617
+536
+8% +$45.7K 0.01% 362
2025
Q2
$644K Sell
7,081
-360
-5% -$32.9K 0.01% 339
2025
Q1
$697K Sell
7,441
-279
-4% -$25K 0.01% 311
2024
Q4
$702K Sell
7,720
-373
-5% -$35.6K 0.01% 282
2024
Q3
$840K Sell
8,093
-875
-10% -$89.2K 0.01% 263
2024
Q2
$808K Buy
8,968
+2,245
+33% +$207K 0.01% 304
2024
Q1
$536K Sell
6,723
-6
-0.1% -$508 0.01% 326
2023
Q4
$536K Buy
6,729
+794
+13% +$59.7K 0.01% 338
2023
Q3
$422K Buy
5,935
+637
+12% +$47.6K 0.01% 363
2023
Q2
$408K Sell
5,298
-234
-4% -$18.1K 0.01% 392
2023
Q1
$416K Sell
5,532
-151,525
-96% -$11.3M 0.01% 349
2022
Q4
$12.4M Buy
157,057
+4,292
+3% +$322K 0.24% 47
2022
Q3
$10.7M Buy
152,765
+475
+0.3% +$37.2K 0.23% 49
2022
Q2
$12.2M Buy
152,290
+7,086
+5% +$554K 0.28% 44
2022
Q1
$11M Buy
+145,204
New +$11.5M 0.22% 46

Other funds holding CL

Mather Group's CL Position: Q1 2026 in Review

Mather Group reduced its Colgate-Palmolive (CL) stake by 0.33% in Q1 2026, selling an estimated $3.21K and leaving 10,990 shares worth $937K. The position accounts for 0.01% of the portfolio, ranked #345.

Mather Group first reported a position in CL in Q1 2022 and has held it in 17 quarters since. The position peaked at $12.4M in Q4 2022. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Mather Group held 10,990 shares of Colgate-Palmolive worth $937K as of Q1 2026.
  • Mather Group sold 36 Colgate-Palmolive shares in Q1 2026, an estimated $3.21K.
  • Colgate-Palmolive made up 0.01% of Mather Group's portfolio in Q1 2026, its #345 holding.
  • Mather Group first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 17 quarters since.
  • Mather Group's Colgate-Palmolive position peaked at $12.4M in Q4 2022.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.